Efforts to roll out coronavirus vaccines have taken various approaches. Experts like Anthony Fauci have suggested that the differences in risk levels between age groups are not as significant as some believe. He argues that everyone should get vaccinated, whether they are young or otherwise healthy.
On the other hand, former CDC Director Rochelle Walensky made claims like, “vaccinated people don’t carry the virus” and “don’t get sick,” which were not only exaggerated but later proven misleading.
Back in 2021-2022, former President Joe Biden warned unvaccinated individuals to brace for a “winter of severe illness and death” and pushed for mandatory vaccinations in workplaces with over 100 employees. There was also talk of vaccine passports and mandates in universities. Stephen Colbert even created a segment called “The Vax-scene,” highlighting some of the absurdities of the situation.
However, another facet of the ongoing vaccination push has involved downplaying or outright denying the potential side effects of the vaccines and how these could affect risk-benefit assessments.
Study highlights potential heart disease risk from vaccines
One avenue to assess side effects is the Vaccine Adverse Event Reporting System (VAERS). Senator Ron Johnson recently shared a report suggesting that the Biden administration may have overlooked important findings from this system while trying to promote vaccine use.
The report stems from a probe by the Standing Subcommittee on Investigations, which sought information from the Department of Health and Human Services regarding the VAERS system in early 2021.
Included in the report is testimony from Dr. Anna Sharfman, a senior medical officer as well as a data mining specialist at the FDA. According to Johnson, she employed modern data analysis to identify numerous statistically significant safety signals tied to COVID-19 vaccines.
Dr. Sharfman supposedly shared her findings with other FDA officials responsible for overseeing vaccine safety. Yet, rather than pursuing further investigation, the report indicates that these officials largely dismissed her work and eventually advised her to cease her analysis.
But what exactly did Dr. Sharfman uncover? Johnson’s report indicates that her analysis found nearly 50 cases of “extreme masking,” a situation where one common data signal can obscure other significant signals. Her findings—and those of Dr. William Dumouchel, an Oracle statistician—suggested that “extreme masking” hid about 20 to 25 significant safety signals for previously undetected side effects, including sudden cardiac death and Bell’s palsy.
Dr. Sharfman actively continued to report on these findings throughout the first half of 2021 as vaccine policies were being established.
However, rather than taking concrete action, the Biden administration and the FDA instructed her to stop her investigations. Johnson’s report mentions that one senior FDA official communicated to colleagues that any discussions with Dr. Sharfman required an in-person meeting due to sensitive considerations.
Another expert, Dr. Peter Marks, cautioned that data mining might create a false dichotomy, potentially fueling anti-vaccination sentiments. By mid-2021, Dr. Sharfman even sent analyses about potential myocarditis links to another FDA official, noting significant safety signals related to acute myocardial infarction.
What action did the FDA take based on these insights? Unfortunately, not much. VAERS has its limitations as a reporting system, but it seems unreasonable that such important data was overlooked without any further investigation.
This pattern of behavior aligns with earlier actions of the FDA and other health authorities—downplaying risks of myocarditis and other health side effects, especially among younger men. This has led to unnecessary risks for college students and others who are less likely to suffer severe illness from COVID-19.
It became increasingly evident that the vaccines had limited efficacy against infection. Yet mandates and requirements persisted based on misleading assumptions.
There seemed to be a disinterest in investigating safety signals, perhaps due to fears that such findings could undermine efforts to promote universal vaccine adoption. This focus on perception over truth raises significant concerns.
It’s possible to be concerned about COVID-19 vaccines without being fundamentally anti-vaccine. But ongoing reports like these highlight disconnects in decision-making among officials, which in turn foster skepticism. Ultimately, it’s a situation that many officials seem unwilling to fully acknowledge.
